|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500101125 |
|
最近更新日期: Date of Last Refreshed on: |
2025-04-21 10:34:42 |
|
注册时间: Date of Registration: |
2025-04-21 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
骨皮质切开同期软硬组织增量术 |
|
Public title: |
Corticotomy and Simultaneous Soft and Hard Tissue Augmentation Surgery |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
骨皮质切开同期软硬组织增量术 |
|
Scientific title: |
Corticotomy and Simultaneous Soft and Hard Tissue Augmentation Surgery |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
段美香 |
研究负责人: |
张明珠 |
|
Applicant: |
Duan Meixiang |
Study leader: |
Zhang Mingzhu |
|
申请注册联系人电话: Applicant telephone: |
+86 184 6918 0207 |
研究负责人电话:
Study leader's |
+86 139 8712 2448 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
2219906423@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
mingzhu_2070@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
昆明医科大学附属口腔医院 |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
|
|
申请注册联系人通讯地址: |
云南省昆明市昆明医科大学附属口腔医院和成国际C座 |
研究负责人通讯地址: |
云南省昆明市昆明医科大学附属口腔医院和成国际C座 |
|
Applicant address: |
Kunming Medical University School and Hospital of Stomatology, Kunming, Yunnan Province, and Hecheng International Building C |
Study leader's address: |
Kunming Medical University School and Hospital of Stomatology, Kunming, Yunnan Province, and Hecheng International Building C |
|
申请注册联系人邮政编码: Applicant postcode: |
650000 |
研究负责人邮政编码: Study leader's postcode: |
650000 |
|
申请人所在单位: |
昆明医科大学附属口腔医院 |
||
|
Applicant's institution: |
Kunming Medical University School and Hospital of Stomatology |
||
|
研究负责人所在单位: |
昆明医科大学附属口腔医院 |
||
|
Affiliation of the Leader: |
Kunming Medical University School and Hospital of Stomatology |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
KYKQ2023MEC0122 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
昆明医科大学附属口腔医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Kunming Medical University School and Hospital of Stomatology |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-12-20 00:00:00 | ||
|
伦理委员会联系人: |
杨春 |
||
|
Contact Name of the ethic committee: |
Yang Chun |
||
|
伦理委员会联系地址: |
云南省昆明市昆明医科大学附属口腔医院和成国际C座 |
||
|
Contact Address of the ethic committee: |
Kunming Medical University School and Hospital of Stomatology, Kunming, Yunnan Province, and Hecheng International Building C |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 138 8827 1676 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
昆明医科大学附属口腔医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Kunming Medical University School and Hospital of Stomatology |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
云南省昆明市昆明医科大学附属口腔医院和成国际C座 |
||||||||||||||||||||||
|
Primary sponsor's address: |
Kunming Medical University School and Hospital of Stomatology, Kunming, Yunnan Province, and Hecheng International Building C |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
无 |
||||||||||||||||||||||
|
Source(s) of funding: |
None |
||||||||||||||||||||||
|
研究疾病: |
牙周软硬组织缺损 |
||||||||||||||||||||||
|
Target disease: |
Periodontal soft and hard tissue defects |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
治疗新技术临床试验 | ||||||||||||||||||||||
|
Study phase: |
New Treatment Measure Clinical Study |
||||||||||||||||||||||
|
研究设计: |
单臂 |
||||||||||||||||||||||
|
Study design: |
Single arm |
||||||||||||||||||||||
|
研究目的: |
1、骨皮质切开同期软硬组织增量术可以同时实现软组织和硬组织增量:改善牙龈退缩和角化龈宽度不足,骨开裂和骨开窗的问题;加速正畸牙移动,缩短正畸时间;减少患者经济、时间成本;提高患者满意度。 2、申报该新技术有助于该技术早日转化为常规技术,将会惠及更多的患者。 |
||||||||||||||||||||||
|
Objectives of Study: |
1.Corticotomy and Simultaneous Soft and Hard Tissue Augmentation Surgery can achieve both soft and hard tissue augmentation at the same time: improving gingival recession and insufficient keratinized gingiva width, as well as addressing issues such as bone dehiscence and bone fenestration; accelerating orthodontic tooth movement, shortening orthodontic treatment time; reducing the economic and time costs for patients; and enhancing patient satisfaction. 2.Applying for this new technology will facilitate its early translation into a routine technique, benefiting a larger number of patients. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1 年龄18以上。 2 下颌左侧尖牙-右侧尖牙区需行PAOO,同时存在个别牙位牙龈退缩。 3 全口菌斑指数及出血指数小于20%。 4 无系统性疾病。 |
||||||||||||||||||||||
|
Inclusion criteria |
1 Age above 18. 2 PAOO is required in the left canine to right canine area of the mandible, with gingival recession present at individual tooth . 3 Plaque index and bleeding index of the entire mouth are less than 20%. 4 No systemic diseases. |
||||||||||||||||||||||
|
排除标准: |
1 存在牙周手术的禁忌证,如血液疾病、免疫系统疾病等全身疾病者。 2 牙周炎活动期。 3 服用激素或影响骨代谢药物的患者。 4 牙龈退缩牙位存在唇侧楔状缺损等其他牙体缺损的患者。 5 前庭沟浅、系带附着高的患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1P resence of contraindications for periodontal surgery, such as blood disorders, immune system diseases, or other systemic diseases. 2A ctive period of periodontitis. 3 Patients taking corticosteroids or medications that affect bone metabolism. 4 Patients with gingival recession accompanied by labial wedge defects or other dental defects at the affected tooth.5 5 Patients with shallow vestibular sulcus and high frenulum attachment. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-12-01 00:00:00至 To 2024-12-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-12-26 00:00:00 至 To 2024-05-21 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2026-07-01后可在国家生物信息中心(https://ngdc.cncb.ac.cn/gsub/)平台公开 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Can be publicly available on the China National Center for Bioinformation platform (https://ngdc.cncb.ac.cn/gsub/) after 2028-07-01. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form, CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |